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The function of the lower urinary tract — to 
store and periodically eliminate urine — seems 
simple, but its neuronal control is complex and 
not fully understood, and dysfunction is common. 
Functional electrical stimulation of the tibial, 
pudendal, and sacral nerves involves spinal cord 
reflexes and brain networks through peripheral 
afferents. These targets for both the inhibition 
and stimulation of lower urinary tract function 
have been potential therapeutic options in urol-
ogy since the 1990s. Although the technology 
has progressively improved, restoration of lower 
urinary tract function has met with limited suc-
cess. A study recently reported by Mickle et al.1 
harnesses optogenetics to control function of the 
lower urinary tract.
Optogenetic approaches, which use light- 
responsive proteins to selectively turn on or off 
specific cell populations, have completely changed 
the ability to modulate cellular activity in a num-
ber of targets. Although the science of neuronal 
control got under way in 1999 when Sir Francis 
Crick first hypothesized that light could be used 
to control the action potential of neurons, it took 
6 years before Boyden and colleagues published 
their seminal work in 2005,2 showing that they 
could stimulate neuronal activation with precise 
timing by transfecting genes encoding light-
activated opsins into specific neurons using a 
viral vector. The activated opsin, in turn, activates 
neuronal firing.
In 2017, Park and colleagues found that they 
could use opsins specifically to stimulate or in-
hibit contraction of smooth-muscle cells in the 
bladder.3 Depolarization of the cells with the use 
of one opsin (channelrhodopsin-2) activated ves-
ical contraction, whereas hyperpolarization with 
another (halorhodopsin) inhibited contraction.3 
Park et al. underscored that a singular advantage 
of the strategy is target specificity through genetic 
delivery (including use of a viral vector) of photo-
sensitive membrane proteins into specific cells 
of the nervous system. Before their study, func-
tional electrical neuromodulation could produce 
simultaneous contraction of both detrusor smooth 
muscle and striated muscle in the external ure-
thral sphincter, which would not be desirable for 
lower urinary tract function.
In their recent study, Mickle et al. modified 
this approach by incorporating optogenetic 
methods to selectively modulate neurons and 
thereby affect bladder function in a rat model. 
They used a closed-loop wireless system with an 
implantable device wrapped around the bladder 
of freely moving rats (Fig. 1). The device mea-
sures changes in resistance during bladder fill-
ing and emptying. For example, when the blad-
der is overactive, a signal is sent to activate a 
small light-emitting diode (LED) which, in turn, 
activates a light-sensitive archaeal protein — an 
inhibitory opsin, archaerhodopsin-3 (Arch), that 
is expressed in specific neural targets — to se-
lectively inhibit the emptying of the bladder, 
thereby restoring normal function. They induced 
inflammation in the otherwise healthy animals 
by intraperitoneal injection of cyclophosphamide 
to test the hypothesis that the activation of Arch 
would reduce neural activity and, by delivering a 
corrective signal, restore bladder storage func-
tion. The results supported the hypothesis: acti-
vation of Arch did indeed reduce neural activity 
and restored normal bladder storage function.
Nevertheless, several issues must be solved 
before optogenetic findings in studies involving 
animals can be translated to daily clinical prac-
tice for lower urinary tract control. The safety of 
the viral vector that is required for optogenetics 
in humans needs to be proved not only in the 
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short term but also in the long term. This chal-
lenge remains a major one, especially consider-
ing that there are still no clinically implemented 
optogenetic applications in humans. In the 
model of Mickle et al., a stretch sensor wrapped 
around the bladder is the key element for moni-
toring lower urinary tract function. Reaction to 
the presence of a foreign body and a dwindling 
of bladder compliance may impede implementa-
tion of this system. Miniaturization of the mod-
ule, enhancing it with a pressure sensor, and 
implanting it directly into the bladder wall — for 
instance, by injecting a combined mini-stretch-
pressure sensor with the use of cystoscopy 
(similar to intradetrusor injections of onabotu-
linumtoxinA) — seems worthy of exploration. 
The thicker bladder wall in humans would prob-
ably impede light transmission, as compared with 
that in rats, and so might warrant different 
light-delivery modes, such as direct placement 
inside the bladder. Red light may be necessary, 
since it penetrates biologic tissue much more 
efficiently than does light of other wavelengths.
Although there are other hurdles to overcome, 
the closed-loop optogenetic neuromodulation sys-
tem developed by Mickle and colleagues opens 
new avenues to restore lower urinary tract func-
tion in humans. As a result of the closed-loop 
Figure 1. Optogenetic Neuromodulation of Urinary Tract Function.
Mickle and colleagues used a closed-loop wireless system with a strain gauge wrapped around the bladder of freely moving rats.1 The 
strain gauge measures changes in resistance during bladder filling and emptying. When the bladder becomes overactive, a signal is sent 
to activate a small microscale inorganic light-emitting diode (μ-ILED), which, in turn, activates a light-sensitive archaeal protein, an opsin, 
to selectively reduce neural activity. This action delivers a corrective signal, thereby restoring normal bladder function.
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system, neuromodulation is only provided when 
the device detects a problem. And, in contrast to 
current functional electrical stimulation of the 
tibial, pudendal, and sacral nerves, optogenetic 
innervation can target specific neurons in the 
lower urinary tract and thus can avoid interfer-
ing with bowel or sexual function.
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
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